A framework for global surveillance of antibiotic resistance

被引:93
作者
Grundmann, Hajo [1 ,2 ]
Klugman, Keith P. [3 ]
Walsh, Timothy [4 ]
Ramon-Pardo, Pilar [5 ]
Sigauque, Betuel [6 ,7 ]
Khan, Wasif [8 ]
Laxminarayan, Ramanan [9 ,10 ]
Heddini, Andreas [11 ]
Stelling, John [12 ]
机构
[1] Univ Groningen, Univ Med Ctr Groningen, Dept Med Microbiol, NL-9713 GZ Groningen, Netherlands
[2] Natl Inst Publ Hlth & Environm RIVM, Bilthoven, Netherlands
[3] Emory Univ, Rollins Sch Publ Hlth, Hubert Dept Global Hlth, Atlanta, GA 30322 USA
[4] Cardiff Univ, Sch Med, Dept Infect Immun & Biochem, Cardiff, S Glam, Wales
[5] PAHO, Communicable Dis Project, Washington, DC USA
[6] Manhica Hlth Res Ctr, Manhica, Mozambique
[7] Minist Hlth, Natl Inst Hlth, Maputo, Mozambique
[8] Int Ctr Diarrhoeal Dis Res, Div Clin Sci, Dhaka 1000, Bangladesh
[9] Ctr Dis Dynam Econ & Policy, Washington, DC USA
[10] Princeton Univ, Princeton Environm Inst, Princeton, NJ 08544 USA
[11] Uppsala Univ, SE-75105 Uppsala, Sweden
[12] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA
关键词
Drug resistance; Bacterial infections; Public health; WHO; Epidemiology; Pharmaceutical economics; Developing countries; Microbiology; Reference laboratories; METALLO-BETA-LACTAMASE; ANTIMICROBIAL RESISTANCE; KLEBSIELLA-PNEUMONIAE; ESCHERICHIA-COLI; CONSUMPTION; COUNTRIES; SYSTEM; UK;
D O I
10.1016/j.drup.2011.02.007
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The foreseen decline in antibiotic effectiveness explains the needs for data to inform the global public health agenda about the magnitude and evolution of antibiotic resistance as a serious threat to human health and development. Opportunistic bacterial pathogens are the cause of the majority of community and hospital-acquired infections worldwide. We provide an inventory of pre-existing regional surveillance programs in the six WHO regions which should form the underpinning for the consolidation of a global network infrastructure and we outline the structural components such as an international network of reference laboratories that need to be put in place to address the void of these crucial data. In addition we suggest to make use of existing Health and Demographic Surveillance Sites (HDSS) to obtain crucial information from communities in resource limited settings at household level in low- and middle-income countries in Asia and Africa. For optimising the use of surveillance data for public health action i.e. priority setting for new drug development, comparative quantification of antibiotic effectiveness at local, national, regional and global level and identification of the action gaps can be helpful. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:79 / 87
页数:9
相关论文
共 39 条
[1]   Antibiotic selection pressure and resistance in Streptococcus pneumoniae and Streptococcus pyogenes [J].
Albrich, WC ;
Monnet, DL ;
Harbarth, S .
EMERGING INFECTIOUS DISEASES, 2004, 10 (03) :514-517
[2]  
Anonymous, 2010, Morbidity and Mortality Weekly Report, V59, P750
[3]  
[Anonymous], 2020, ANN REPORT EUROPEAN
[4]  
[Anonymous], EURO SURVEILL
[5]  
[Anonymous], COR FUNCT MICR REF L
[6]  
[Anonymous], NY TIMES
[7]  
[Anonymous], 2010, NAT ACC MAIN AGGR DA
[8]  
*BIOSP AS, 2009, HOSP ACQ ORCH GEN IN
[9]   High rate of fatal cases of pediatric septicemia caused by gram-negative bacteria with extended-spectrum beta-lactamases in Dar es Salaam, Tanzania [J].
Blomberg, B ;
Jureen, R ;
Manji, KP ;
Tamim, BS ;
Mwakagile, DSM ;
Urassa, WK ;
Fataki, M ;
Msangi, V ;
Tellevik, MG ;
Maselle, SY ;
Langeland, N .
JOURNAL OF CLINICAL MICROBIOLOGY, 2005, 43 (02) :745-749
[10]   Comparability of antimicrobial susceptibility test results from 22 European countries and Israel: an external quality assurance exercise of the European Antimicrobial Resistance Surveillance System (EARSS) in collaboration with the United Kingdom National External Quality Assurance Scheme (UK NEQAS) [J].
Bronzwaer, S ;
Buchholz, U ;
Courvalin, P ;
Snell, J ;
Cornaglia, G ;
de Neeling, A ;
Aubry-Damon, H ;
Degener, J .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2002, 50 (06) :953-964